Literature DB >> 14530444

The inflammation-induced down-regulation of plasma Fetuin-A (alpha2HS-Glycoprotein) in liver results from the loss of interaction between long C/EBP isoforms at two neighbouring binding sites.

Christophe Gangneux1, Maryvonne Daveau, Martine Hiron, Céline Derambure, John Papaconstantinou, Jean-Philippe Salier.   

Abstract

Fetuin-A is an hepatic protein whose mRNA transiently falls during the inflammatory acute phase via unknown transcriptional mechanisms. Various FETUA promoter/cat constructs transiently transfected in the Hep3B hepatoma cell line allowed us to identify four NF-1 and C/EBP binding sites (N, C) arranged in a 5'-N2-C2-N1-C1-3' order and required for basal promoter activity. Mutant constructs demonstrated that C1 and C2 but not N1 nor N2 are required for the cytokine-driven down-regulation of the promoter. A variable spacing between C2 and N1 showed that the alignment of the (C1+N1) and (C2+N2) areas is critical for the promoter activity in quiescent but not cytokine-stimulated cells. Co-transfection of a plasmid only producing either a long or short C/EBPbeta isoform prevented FETUA regulation by cytokines. Electromobility shift assays with liver nuclear extracts showed that during the acute phase the complexes formed over N1 and N2 are not modified whereas short C/EBPalpha and -beta isoforms replace the long isoforms bound to C1 and C2 in the quiescent liver. Therefore the basal promoter activity requires an interaction between the long C/EBP isoforms bound to C1 and C2 whereas the inflammation-induced down-regulation results from the loss of interaction between the cytokine-induced, short C/EBP isoforms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14530444      PMCID: PMC219469          DOI: 10.1093/nar/gkg788

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  50 in total

1.  Fetuin, a negative acute phase protein, attenuates TNF synthesis and the innate inflammatory response to carrageenan.

Authors:  M Ombrellino; H Wang; H Yang; M Zhang; J Vishnubhakat; A Frazier; L A Scher; S G Friedman; K J Tracey
Journal:  Shock       Date:  2001-03       Impact factor: 3.454

2.  Nuclear factor I/CCAAT box transcription factor trans-activating domain is a negative sensor of cellular stress.

Authors:  Y Morel; X Coumoul; A Nalpas; R Barouki
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

3.  Regulation of CCAAT/enhancer-binding protein-beta isoform synthesis by alternative translational initiation at multiple AUG start sites.

Authors:  W Xiong; C C Hsieh; A J Kurtz; J P Rabek; J Papaconstantinou
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

4.  Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor.

Authors:  S T Mathews; N Chellam; P R Srinivas; V J Cintron; M A Leon; A S Goustin; G Grunberger
Journal:  Mol Cell Endocrinol       Date:  2000-06       Impact factor: 4.102

5.  Tumor necrosis factor alpha inhibits type I collagen synthesis through repressive CCAAT/enhancer-binding proteins.

Authors:  P Greenwel; S Tanaka; D Penkov; W Zhang; M Olive; J Moll; C Vinson; M Di Liberto; F Ramirez
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

6.  Translational induction of liver-enriched transcriptional inhibitory protein during acute phase response leads to repression of CCAAT/enhancer binding protein alpha mRNA.

Authors:  A L Welm; S L Mackey; L T Timchenko; G J Darlington; N A Timchenko
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

7.  p53 represses CAAT enhancer-binding protein (C/EBP)-dependent transcription of the albumin gene. A molecular mechanism involved in viral liver infection with implications for hepatocarcinogenesis.

Authors:  S Kubicka; F Kühnel; L Zender; K L Rudolph; J Plümpe; M Manns; C Trautwein
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

8.  Positive and negative elements modulate the promoter of the human liver-specific alpha2-HS-glycoprotein gene.

Authors:  F Banine; C Gangneux; L Mercier; A Le Cam; J P Salier
Journal:  Eur J Biochem       Date:  2000-02

9.  Translational control of C/EBPalpha and C/EBPbeta isoform expression.

Authors:  C F Calkhoven; C Müller; A Leutz
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

10.  Fetuin (alpha2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules.

Authors:  H Wang; M Zhang; M Bianchi; B Sherry; A Sama; K J Tracey
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more
  20 in total

1.  Fetuin-A, a hepatocyte-specific protein that binds Plasmodium berghei thrombospondin-related adhesive protein: a potential role in infectivity.

Authors:  Deepa Jethwaney; Timothy Lepore; Saria Hassan; Kerrianne Mello; Radha Rangarajan; Willi Jahnen-Dechent; Dyann Wirth; Ali A Sultan
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Association of alpha2-HS glycoprotein (AHSG, fetuin-A) polymorphism with AHSG and phosphate serum levels.

Authors:  Motoki Osawa; Wei Tian; Hidekazu Horiuchi; Mika Kaneko; Kazuo Umetsu
Journal:  Hum Genet       Date:  2004-12-09       Impact factor: 4.132

3.  Estrogen increases the transcription of human α2-Heremans-Schmid-glycoprotein by an interplay of estrogen receptor α and activator protein-1.

Authors:  C Qiu; X Liu; J Wang; Y Zhao; Q Fu
Journal:  Osteoporos Int       Date:  2014-02-07       Impact factor: 4.507

4.  AHSG gene variant is associated with leanness among Swedish men.

Authors:  Catharina Lavebratt; Sofia Wahlqvist; Louise Nordfors; Johan Hoffstedt; Peter Arner
Journal:  Hum Genet       Date:  2005-04-02       Impact factor: 4.132

5.  Fetuin-A, a new vascular biomarker of cognitive decline in older adults.

Authors:  Gail A Laughlin; Linda K McEvoy; Elizabeth Barrett-Connor; Lori B Daniels; Joachim H Ix
Journal:  Clin Endocrinol (Oxf)       Date:  2014-01-07       Impact factor: 3.478

6.  Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B.

Authors:  Guo-Hua Qiu; Xiaojin Xie; Fang Xu; Xiaohao Shi; Yue Wang; Linhong Deng
Journal:  Cytotechnology       Date:  2014-07-08       Impact factor: 2.058

7.  Chlamydia muridarum infection associated host MicroRNAs in the murine genital tract and contribution to generation of host immune response.

Authors:  Rishein Gupta; Tanvi Arkatkar; Jieh-Juen Yu; Shradha Wali; William E Haskins; James P Chambers; Ashlesh K Murthy; Sazaly Abu Bakar; M Neal Guentzel; Bernard P Arulanandam
Journal:  Am J Reprod Immunol       Date:  2014-06-28       Impact factor: 3.886

Review 8.  Inflammation and the osteogenic regulation of vascular calcification: a review and perspective.

Authors:  Jian-Su Shao; Su-Li Cheng; Justin Sadhu; Dwight A Towler
Journal:  Hypertension       Date:  2010-01-25       Impact factor: 10.190

9.  Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis.

Authors:  Roman Fischer; David C Trudgian; Cynthia Wright; Gethin Thomas; Linda A Bradbury; Matthew A Brown; Paul Bowness; Benedikt M Kessler
Journal:  Mol Cell Proteomics       Date:  2011-10-13       Impact factor: 5.911

10.  Plasma Proteomic Analysis in Morquio A Disease.

Authors:  José V Álvarez; Susana B Bravo; María Pilar Chantada-Vázquez; Sofía Barbosa-Gouveia; Cristóbal Colón; Olalla López-Suarez; Shunji Tomatsu; Francisco J Otero-Espinar; María L Couce
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.